[多形性胶质母细胞瘤术后使用放射增敏剂（5-溴-2-脱氧尿苷）的治疗结果] - Suppr

Suppr

超能文献

[Results of postoperative treatment of glioblastoma multiforme with a radiation-sensitizing substance (5-bromo-2-deoxyuridine)].

作者信息

Landolt A M

出版信息

Acta Neurochir (Wien). 1971;24(4):263-8. doi: 10.1007/BF01405412.

DOI:10.1007/BF01405412

PMID:4332090

Abstract

摘要

相似文献

[Results of postoperative treatment of glioblastoma multiforme with a radiation-sensitizing substance (5-bromo-2-deoxyuridine)].[多形性胶质母细胞瘤术后使用放射增敏剂（5-溴-2-脱氧尿苷）的治疗结果]

Acta Neurochir (Wien). 1971;24(4):263-8. doi: 10.1007/BF01405412.

Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study.

Int J Radiat Oncol Biol Phys. 1991 Aug;21(3):709-14. doi: 10.1016/0360-3016(91)90690-6.

A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.一项针对多形性胶质母细胞瘤的II期试验，采用高剂量溴脱氧尿苷联合加速分割放疗，随后给予丙卡巴肼、洛莫司汀和长春新碱。

Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):127-35. doi: 10.1016/s0360-3016(99)00122-4.

Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.溴脱氧尿苷放射增敏对恶性胶质瘤患者生存的影响：对来自北加利福尼亚肿瘤学组（NCOG）和放射治疗肿瘤学组（RTOG）针对多形性胶质母细胞瘤和间变性星形细胞瘤的试验生存数据的回顾性比较。

Int J Radiat Oncol Biol Phys. 1998 Feb 1;40(3):653-9. doi: 10.1016/s0360-3016(97)00770-0.

[How useful are microsurgical operations in the treatment concept for glioblastoma multiforme].[显微外科手术在多形性胶质母细胞瘤治疗理念中的作用如何]

MMW Fortschr Med. 2004 Apr 1;146(14):28-30.

Halogenated pyrimidines as radiosensitizers for high grade glioma: revisited.卤代嘧啶作为高级别胶质瘤的放射增敏剂：再探讨

Int J Radiat Oncol Biol Phys. 1991 Aug;21(3):859-62; discussion 865. doi: 10.1016/0360-3016(91)90710-l.

[Significance of the combined use of radiosensitizing agents on radiotherapy of malignant encephaloma].[放射增敏剂联合应用在恶性脑肿瘤放射治疗中的意义]

Rinsho Hoshasen. 1968 Nov;13(11):885-91.

Clinical trial of intravenous infusion of bromodeoxyuridine (BUdR) for radiosensitization of malignant brain tumors.静脉输注溴脱氧尿苷（BUdR）用于恶性脑肿瘤放射增敏的临床试验。

Radiat Med. 1988 Jan-Feb;6(1):33-9.

Halogenated pyrimidines as radiosensitizers in the treatment of glioblastoma multiforme.卤代嘧啶作为多形性胶质母细胞瘤治疗中的放射增敏剂。

Am J Clin Oncol. 1987 Oct;10(5):437-43. doi: 10.1097/00000421-198710000-00014.

[Temozolomide in patients with a glioblastoma multiforme: new developments].[替莫唑胺治疗多形性胶质母细胞瘤患者：新进展]

Ned Tijdschr Geneeskd. 2005 Jun 18;149(25):1376-8.

本文引用的文献

[Anamnesis and clinical picture of glioblastoma multiforme].[多形性胶质母细胞瘤的病史及临床表现]

Acta Neurochir Suppl (Wien). 1959;6:31-9.

The growth of glioblastoma multiforme (astrocytomas, grades 3 and 4) in neurosurgical practice.多形性胶质母细胞瘤（星形细胞瘤，3级和4级）在神经外科实践中的生长情况。

J Neurosurg. 1961 Sep;18:636-44. doi: 10.3171/jns.1961.18.5.0636.

The Kentucky Conference on Brain Tumor Chemotherapy.肯塔基脑肿瘤化疗会议

J Neurosurg. 1967 Jul;27(1):1-10. doi: 10.3171/jns.1967.27.1.0001.

Current trends in the chemotherapy of brain tumors with special reference to glioblastomas.脑肿瘤化疗的当前趋势，特别提及胶质母细胞瘤。

J Neurosurg. 1969 Dec;31(6):589-603. doi: 10.3171/jns.1969.31.6.0589.

The treatment of glioblastoma multiforme of the brain.

J Neurosurg. 1967 Nov;27(5):388-400. doi: 10.3171/jns.1967.27.5.0388.

Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).用胸苷类似物（溴尿苷）对脑肿瘤细胞进行放射增敏作用。

J Neurosurg. 1968 Jun;28(6):530-8. doi: 10.3171/jns.1968.28.6.0530.

Experimental and clinical studies of radiosensitizers in brain tumors, with special reference to BUdR-antimetabolite continuous regional infusion-radiation therapy (BAR therapy).脑肿瘤放射增敏剂的实验与临床研究，特别提及5-溴脱氧尿苷-抗代谢物持续区域灌注-放射治疗（BAR疗法）。

Neurol Med Chir (Tokyo). 1965;7:51-72. doi: 10.2176/nmc.7.51.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验